checkAd

     134  0 Kommentare Erasca Announces Exclusive Worldwide License for Pan-RAF Inhibitor Naporafenib - Seite 3



    MEKINIST is a registered trademark owned by or licensed to Novartis AG, its subsidiaries, or affiliates.

    Contact:
    Joyce Allaire
    LifeSci Advisors, LLC
    jallaire@lifesciadvisors.com

    Lesen Sie auch

    Source: Erasca, Inc.



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3
    Verfasst von globenewswire
    Erasca Announces Exclusive Worldwide License for Pan-RAF Inhibitor Naporafenib - Seite 3 Concurrent $100 million equity offering Naporafenib has a potential first-in-class and best-in-class profile in multiple RAS/MAPK pathway-driven tumors Pivotal-ready asset has been dosed in over 500 patients to date and expands Erasca’s …